Nektar Therapeutics | Gewinn Je Aktie

Aktienkurs
65.48
Täglich Wechseln
9.48 16.93%
Monatlich
68.89%
Jährlich
497.17%
Q1 Prognose
1.21




Eps Veränderung Datum
Agios Pharmaceuticals USD -1.78 0.15 2025-09
ALKERMES USD 0.49 0.03 2025-09
Alterity Therapeutics Limited AUD 0 0 2023-12
Amgen USD 5.29 0.35 2025-12
Baxter International USD 0.69 0.1 2025-09
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Cara Therapeutics USD -5.04 3.24 2024-12
Cipla INR 15.2 1.52 2025-12
Dr.Reddys Laboratories INR 14.52 2.98 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 0.97 0.19 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Grifols EUR 0.26 0.06 2025-09
Halozyme Therapeutics USD 1.72 0.18 2025-09
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
Ironwood Pharmaceuticals USD 0.24 0.1 2025-09
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 0.27 0.84 2025-09
Merck USD 2.04 0.54 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 2.17 0.52 2025-09
Novartis USD 2.04 0.38 2025-09
Pfizer USD 0.66 0.21 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD -0.13 2.15 2025-09
Takeda JPY 65.74 73.57 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Xencor USD -0.08 0.33 2025-09


Nektar Therapeutics Gewinn Je Aktie - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.